Atrion
As a leading manufacturer of medical devices and components, Atrion makes a wide range of products for specific niche markets.
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 4 % | 2 % | (5 %) | 12 % | 11 % | (8 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 34 % | 33 % | 26 % | 23 % | 21 % | 22 % | 23 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 25 % | 22 % | 24 % | 22 % | 20 % | 19 % | 11 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 4 % | 4 % | 3 % | 4 % | 3 % | 3 % | 4 % |
Source: Company filings or news article
Related Content
Atrion Corporation, a name synonymous with innovation in the medical device industry, has a storied history that began with its founding. While specific details about the founders remain elusive, the company has been steered by influential leaders like David Battat, who served as CEO, guiding Atrion through pivotal moments in its journey.
Atrion carved a niche for itself by developing and manufacturing specialized medical devices, particularly in the fields of cardiovascular, ophthalmology, and fluid delivery systems. These innovations have been crucial in advancing medical procedures and improving patient outcomes globally.
A significant chapter in Atrion's history unfolded in 2024 when Nordson Corporation, a leader in precision technology solutions, acquired Atrion. This acquisition, valued at approximately $810 million, marked a new era for Atrion, integrating its expertise with Nordson's expansive resources and global reach. The merger was structured to allow Atrion to continue its operations as a surviving corporation, ensuring the legacy of its innovations would persist.
This acquisition not only underscored Atrion's value in the medical device sector but also highlighted the strategic importance of its technologies in enhancing Nordson's portfolio. As part of Nordson, Atrion is poised to further its impact on the medical field, continuing to innovate and deliver solutions that address critical healthcare needs.